Bank of New York Mellon
OXFD

Bank of New York Mellon’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bank of New York Mellon’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-72,117
Closed -$1.24M – 4316
2019
Q1 		$1.24M Buy
72,117
+2,091
+3% +$33.1K ﹤0.01% 3032
2018
Q4 		$895K Sell
70,026
-401
-0.6% -$6.08K ﹤0.01% 3172
2018
Q3 		$1.14M Buy
70,427
+514
+0.7% +$7.35K ﹤0.01% 3190
2018
Q2 		$902K Buy
69,913
+682
+1% +$9.21K ﹤0.01% 3303
2018
Q1 		$863K Sell
69,231
-509
-0.7% -$6.2K ﹤0.01% 3297
2017
Q4 		$975K Buy
69,740
+6,017
+9% +$88.1K ﹤0.01% 3267
2017
Q3 		$1.07M Buy
63,723
+1,157
+2% +$18.8K ﹤0.01% 3182
2017
Q2 		$1.05M Buy
62,566
+7,435
+13% +$111K ﹤0.01% 3220
2017
Q1 		$854K Sell
55,131
-15,175
-22% -$217K ﹤0.01% 3321
2016
Q4 		$1.05M Buy
70,306
+1,117
+2% +$15.7K ﹤0.01% 3234
2016
Q3 		$869K Buy
69,189
+17,290
+33% +$174K ﹤0.01% 3247
2016
Q2 		$467K Buy
51,899
+10,809
+26% +$106K ﹤0.01% 3571
2016
Q1 		$407K Buy
41,090
+1,250
+3% +$12.8K ﹤0.01% 3530
2015
Q4 		$458K Sell
39,840
-180
-0.4% -$2.23K ﹤0.01% 3563
2015
Q3 		$540K Sell
40,020
-14,858
-27% -$201K ﹤0.01% 3548
2015
Q2 		$759K Buy
54,878
+11,126
+25% +$150K ﹤0.01% 3476
2015
Q1 		$616K Buy
43,752
+3,875
+10% +$52.7K ﹤0.01% 3523
2014
Q4 		$542K Sell
39,877
-1,045
-3% -$14.3K ﹤0.01% 3588
2014
Q3 		$625K Sell
40,922
-15,750
-28% -$241K ﹤0.01% 3543
2014
Q2 		$953K Buy
56,672
+21,366
+61% +$385K ﹤0.01% 3341
2014
Q1 		$709K Buy
35,306
+15,188
+75% +$329K ﹤0.01% 3444
2013
Q4 		$389K Buy
+20,118
New +$356K ﹤0.01% 3665

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Bank of New York Mellon's OXFD Position: Q2 2019 in Review

Bank of New York Mellon sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2019, closing a stake of 72,117 shares — an estimated $1.24M sold.

Bank of New York Mellon first reported a position in OXFD in Q4 2013 and held it in 22 quarters. The position peaked at $1.24M in Q1 2019. 86 funds tracked by Wall St. Rank hold OXFD as of Q2 2019.

  • Bank of New York Mellon reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2019 after selling out during the quarter.
  • Bank of New York Mellon sold 72,117 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2019, an estimated $1.24M.
  • Bank of New York Mellon first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 22 quarters.
  • Bank of New York Mellon's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.24M in Q1 2019.
  • 86 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2019.

Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.